Related Experiment Video
Updated: Jul 2, 2025

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Antibiotics for Patients With a Planned Re-Laparotomy for Intra-Abdominal Infection
Lauren J Hochstetler1, William J Olney1,2, Jacqueline M Bishop1,2
1Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, Kentucky, USA.
Abstract:
Background: Appropriate antimicrobial therapy for the management of intra-abdominal infection (IAI) continues to evolve based on available literature. The Study to Optimize Peritoneal Infection Therapy (STOP-IT) trial provided evidence to support four days of antibiotic agents in IAI post-source control but excluded patients with a planned re-laparotomy. This study aimed to determine the short- and long-term recurrent infection risk in this population. Patients and Methods: This is a single-center, retrospective, observational study of adult patients admitted to a quaternary medical center between January 1, 2016, and August 1, 2022, with IAI requiring planned laparotomy. Patients were designated as receiving five or less days of antibiotic agents (short course) or more than five days (long course) after source control. The primary outcome was IAI recurrence within 30 days. Results: Of the 104 patients who met inclusion criteria, 78 were included in analysis. Average age was 57 ± 13.3 years, 56% were male, 94% Caucasian, with a mean Acute Physiology and Chronic Health Evaluation (APACHE) II score of 17 ± 7.09. All other baseline characteristics and clinical severity markers were similar between the two groups. Regarding the primary outcome of IAI recurrence, there was no difference when comparing those who received short course versus those who received long course therapy (41.2% vs. 44.4%; p = 0.781). No differences were found between groups with respect to secondary outcomes. Conclusions: In patients admitted with IAI managed with planned re-laparotomy those who received short course antimicrobial therapy were not found to have an increase in IAI recurrence compared to those with longer courses of therapy.
Insights
Shorter antibiotic courses (≤5 days) for intra-abdominal infections (IAI) requiring planned re-laparotomy did not increase recurrence risk compared to longer courses. This finding supports optimizing antimicrobial therapy duration in complex IAI cases.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Antimicrobial Stewardship
Background:
- Intra-abdominal infections (IAI) management requires appropriate antimicrobial therapy, with evolving evidence on optimal duration.
- The STOP-IT trial suggested shorter antibiotic courses for IAI but excluded patients needing re-laparotomy.
- Determining the recurrence risk associated with shorter antibiotic courses in patients with planned re-laparotomy is crucial.
Purpose of the Study:
- To evaluate the short-term and long-term risk of recurrent intra-abdominal infection (IAI) in patients managed with planned re-laparotomy.
- To compare IAI recurrence rates between patients receiving short-course (≤5 days) versus long-course (>5 days) antimicrobial therapy post-source control.
- To assess the impact of antimicrobial therapy duration on secondary outcomes in this specific patient population.
Main Methods:
- A single-center, retrospective, observational study was conducted on adult patients with IAI requiring planned laparotomy.
- Patients were categorized into short-course (≤5 days) and long-course (>5 days) antimicrobial therapy groups after source control.
- The primary outcome was the recurrence of IAI within 30 days, with secondary outcomes also analyzed.
Main Results:
- Of 104 eligible patients, 78 were analyzed. Baseline characteristics and clinical severity were similar between groups.
- No significant difference in IAI recurrence was observed between the short-course and long-course antimicrobial therapy groups (41.2% vs. 44.4%; p=0.781).
- No differences were found between the groups regarding secondary outcomes.
Conclusions:
- In patients with IAI managed with planned re-laparotomy, short-course antimicrobial therapy did not lead to an increased risk of IAI recurrence.
- These findings suggest that shorter antimicrobial durations may be safe and effective in select IAI patients requiring planned re-laparotomy.
- Further research may refine antimicrobial stewardship guidelines for complex intra-abdominal infections.
More Related Videos
09:49Surgical Closure of Equine Abdomen, Prevention, and Management of Incisional Complications
Published on: May 10, 2024
04:01Indocyanine Green-Guided Intraoperative Imaging to Facilitate Video-Assisted Retroperitoneal Debridement for Treating Acute Necrotizing Pancreatitis
Published on: September 8, 2022
Related Concept Videos
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Appendicitis-II: Diagnostic Studies and Management
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD: